Free Trial
→ Trump currency shock imminent (From Stansberry Research) (Ad)

GlucoTrack Q4 2023 Earnings Report

GlucoTrack logo
$0.12 +0.04 (+47.23%)
As of 01/21/2025 04:00 PM Eastern
Earnings History

GlucoTrack EPS Results

Actual EPS
-$0.50
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

GlucoTrack Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

GlucoTrack Announcement Details

Quarter
Q4 2023
Date
3/28/2024
Time
N/A

Conference Call Resources

GlucoTrack Earnings Headlines

Glucotrack, Inc. Achieves ISO 13485:2016 Certification for Quality Management On January 21, 2025, Glucotrack, Inc. (NASDAQ: GCTK) made a significant stride by acquiring ISO13485:2016 certification from the British Standards Institute. The certific
January 22 at 2:11 AM | americanbankingnews.com
Glucotrack Announces ISO 13485:2016 Certification
January 21 at 8:01 AM | globenewswire.com
Trump currency shock imminent
Trump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launched a $1.9 trillion move against the Fed. What comes next could have dramatic consequences.
January 22, 2025 | Stansberry Research (Ad)
GlucoTrack (NASDAQ: IGAP)
January 16, 2025 | fool.com
GlucoTrack appoints Ted Williams as VP, regulatory affairs
January 16, 2025 | markets.businessinsider.com
Glucotrack Strenghtens Leadership Team with Addition of Industry Veteran as Vice President of Regulatory Affairs
January 15, 2025 | globenewswire.com
See More GlucoTrack Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like GlucoTrack? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GlucoTrack and other key companies, straight to your email.

About GlucoTrack

GlucoTrack (NASDAQ:GCTK), a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

View GlucoTrack Profile

More Earnings Resources from MarketBeat

Earnings Tools
Earnings By Country
Latest Articles